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A B S T R A C T
A 50-year-old female patient with a history of prior acute inferior myocardial infarc-
tion successfully treated 2 years earlier by primary percutaneous coronary interven-
tion (PCI) with thrombus aspiration and implantation of a 3x30 mm bare-metal stent 
in the proximal right coronary artery (RCA) was submitted to coronary angiography 
after reappearance of effort angina. An initial coronary angiogram showed a chronic 
total occlusion (CTO) intra-stent with Rentrop III collateral filling of the RCA origi-
nating from distal left anterior descending (LAD). A mid LAD 60% stenosis and a 
60% mid circumflex stenosis were considered non-significant since fractional flow re-
serve (FFR) was measured at 0.84 and 0.90 respectively. After demonstrating inferior 
wall viability by cardiac magnetic resonance imaging (MRI), a PCI was programmed 
two months after the initial coronary angiogram. The intra-stent CTO was  30 mm 
long, with no blunt stump and at least 2 small branches originating at its proximal cap 
level. Mid and distal RCA antegrade filling existed due to bridging collaterals. The 
crossing technique by guidewire exchange and use of a microcatheter is described. 
After balloon predilatation the RCA was recanalized. The use of a stent visualization 
enhancement technology (StentViz) helped understand the most probable procedure-
related restenosis mechanisms (stent undersizing and underexpansion) and guided 
the subsequent successful implantation of two drug-eluting stents. The use of this 
technology is described step by step for this intervention. 
I N T R O D U C T I O N
Innovations in medical imaging technology are particularly important in interven-
tional cardiology. Assessment of an implanted stent during percutaneous coronary 
interventions (PCI) is crucial to minimize the risk of adverse events such as thrombosis 
and restenosis due to technical inadequacies. Conventional fluoroscopic imaging is 
simple but has inherent limitations. Intravascular ultrasound or optical coherence 
tomography require further intervention with use of additional and expensive tools 
and equipment with extra effort and risk. Stent visualization enhancement technology 
is available in some latest angiography suites, with more characteristic examples the 
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StentViz and the StentBoost protocols. A cine run of 3 sec-
onds at 15 fps is acquired with the balloon and stent markers 
in place. With the press of a button the software automati-
cally detects both the guidewire and the stent markers. Its 
simplicity offers the possibility of immediate and routine 
control of stent deployment. We herein describe the use 
of this novel noninvasive technology in a patient undergo-
ing PCI for a chronic total occlusion (CTO) of the right 
coronary artery (RCA). 
C A S E  R E P O R T
A 50-year-old woman having as risk factors active smoking 
and dyslipidemia was admitted because of reappearance of 
effort angina. She had a history of acute inferior myocardial 
infarction 2 years earlier successfully treated by primary PCI 
with thrombus aspiration and implantation of a 3x30 mm bare-
metal stent in the proximal RCA. An initial coronary angiogra-
phy showed a mid- left anterior descending artery (LAD) 60% 
stenosis and a 60% mid- circumflex (Cx) stenosis which were 
both considered non-significant since fractional flow reserve 
(FFR) was measured 0.84 and 0.90 respectively. The proximal 
RCA had a CTO intra-stent with Rentrop III retrograde fill-
ing via collaterals until its middle segment originating from 
the distal LAD. The intra-stent occlusion was  30 mm long, 
without blunt stump and at least 2 small branches originating at 
its proximal cap level (Fig. 1 A). Distal RCA antegrade filling 
was present due to bridging collaterals (Fig. 1 B).
After a cardiac magnetic resonance imaging study that 
demonstrated presence of viability in the inferior wall, a PCI 
attempt to recanalize the RCA was programmed two months 
after the initial angiogram. The femoral approach was chosen 
to optimize support and the RCA ostium was cannulated 
with a 6 French Judkins right-4 guiding catheter. Due to the 
presence of antegrade mid and distal RCA filling, despite 
the presence of bridging collaterals, the possibility of micro-
channel presence in the occlusion led to the choice of a Fielder 
XT (Asahi Intec, Abbot Vascular) as initial guidewire. After 
failure to cross, the Fielder XT and a BMW (Abbot Vascular) 
guidewires were positioned into the two branches originating 
at the proximal cap level in order to help direct a PILOT 50 
(Abbot Vascular) guidewire into the occlusion instead of into 
those branches. The PILOT 50 crossed the proximal cap but 
could not be advanced more than 20 mm into the occlusion 
(Fig. 2 A). After exchanging the PILOT 50 with a CROSS-IT 
200 (Abbot Vascular) over a Finecross microcatheter (Terumo 
Cardiovascular Systems Corp.), the distal cap was crossed but 
there was evidence of subintimal position of the guidewire in 
the mid RCA (Fig. 2 B). With the support of the Finecross, 
the CROSS-IT 200 was exchanged with a BMW which could 
find the true lumen and was advanced into the distal RCA 
(Fig. 2 C). After wire crossing simple “dottering” with a 2x20 
mm balloon restored RCA antegrade flow and there was 
evidence of a tight lesion immediately distally to the distal 
stent edge (Fig. 2 D).
After intra-stent predilatation with the 2x20 mm balloon 
and intra-coronary nitrates, flow was further improved and 
the mid and distal RCA diameter was estimated to be 3.5 mm 
while the initially implanted stent was a 3x30 mm bare-metal 
stent (Fig. 3 A). An initial image with StentViz further showed 
FIGURE 1. A. Left anterior oblique (LAO) view showing a 
chronic intra-stent occlusion of the proximal RCA. The occlu-
sion is at least as long as the implanted bare-metal stent (30 
mm), there is no blunt stump and at least two side branches 
originate at the proximal cap level. B. Cranial view: slow ante-
grade flow in the middle and distal RCA by bridging collaterals. 
A small marginal branch at proximal RCA provides flow to the 
distal part of a similar marginal branch originating from the mid-
dle RCA as shown by the arrows. RCA = right coronary artery
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FIGURE 2. A. After failure to cross, a 
Fielder XT and a BMW guidewires are 
positioned in two small side branches origi-
nating at the CTO proximal cap level. A 
PILOT 50 crosses and can be advanced 
midway into the occlusion (red arrow). B. 
The PILOT 50 can not be further advanced 
and with the aid of a Finecross microcath-
eter (white arrow) it is exchanged with a 
CROSS-IT 200 which crosses the distal cap 
but is advanced subintimally. C. With the 
support of the Finecross, the CROSS-IT 
200 is exchanged with a BMW wire which 
finds the true lumen and is advanced into 
the distal RCA. D. After wire crossing and 
balloon ‘’dottering’’ there is flow restora-
tion and evidence of a tight lesion just after 
the distal stent edge (red arrow). CTO = 
chronic total occlusion
FIGURE 3. A. Angiographic image after in-
tra-stent pre-dilatation with a 2x20 mm bal-
loon. The RCA reference diameter seems 
to be 3.5 mm, while the implanted stent was 
a 3x30 mm BMS. B. StentViz after pre-dil-
atation with the 2x20 mm balloon: the stent 
has a waist at its mid part (underexpansion 
area). C. Angiographic image after further 
intra-stent pre-dilatation with a 3x15 mm 
non-compliant balloon at high pressure. 
The red arrow shows the tight lesion just 
distal to the distal stent edge. The artery 
seems definitely to have a reference diam-
eter of 3.5 mm, so the initial stent was un-
dersized. D. StentViz after pre-dilatation 
with the 3x15 mm non-compliant balloon: 
the waist at the stent mid-part has disap-
peared and there is a diameter gain com-
pared to B. RCA = right coronary artery
that the mid part of the stent had a waist area where it was 
probably underexpanded (Fig. 3 B). Therefore undersizing and 
underexpansion were two obvious procedure related factors 
contributing to the diffuse occlusive restenosis process in this 
case. Subsequent intra-stent pre-dilatation with a 3x15 mm 
non-compliant balloon at high pressure further ameliorated 
flow, the tight lesion just distal to the distal stent edge was 
better depicted and the proximal to mid RCA length to be 
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stented with drug-eluting stents (DES) was estimated to be 
about 50 mm (Fig. 3 C). StentViz imaging after predilatation 
with the 3x15 mm balloon showed that the waist at the stent 
mid-part had disappeared and that there was a diameter gain 
at this zone (Fig. 3 D).
Since using a DES of 3.5 mm diameter seemed appropri-
ate, there was further predilatation with a 3.5x15 mm non 
compliant balloon, at high-pressure intra-stent and at nominal 
pressure on the tight lesion after the distal stent edge, with 
further improvement of the angiographic result (Fig. 4 A). 
A TAXUS Element (Boston Scientific) 3.5x38 mm DES was 
subsequently implanted to completely cover the old stent and 
the proximal part of the mid RCA lesion (Fig. 4 B). StentViz 
after the long DES implantation depicted the proximal and 
the distal edges of the two-layer stent area which was more 
opaque (Fig. 4 C). The long DES was not sufficient to cover 
the post-stent mid RCA lesion and a TAXUS 3.5x12 mm 
overlapping stent was also implanted under StentViz control 
to ensure accurate positioning with a minimal 1-2 mm over-
lapping zone, while avoiding the inadvertent implantation too 
proximally which would create an undesired three-layer stent 
zone. StentViz after the second DES implantation showed 
that the second DES was implanted as intended (Fig. 4 D). 
Final post-dilatations intra-stent for the whole stented area 
followed with the 3.5x15 mm non-compliant balloon at high 
pressures (up to 24 Atm). StentViz was used before and after 
each post-dilatation in order to ensure adequate stent expan-
sion at all levels (Fig. 5 A, B and C). The final angiographic 
result was optimal (Fig. 5 D).
D I S C U S S I O N
Breakthroughs in medical imaging technology are espe-
cially important in interventional cardiology since they increase 
diagnostic confidence as well as intervention planning and 
performance. Post-implantation stent assessment during an-
gioplasty procedures is crucial to minimize the risk of future 
events such as restenosis and thrombosis. However, conven-
tional fluoroscopic imaging has limitations and is inadequate 
for this purpose. Stent visualization enhancement technol-
ogy is available in some latest angiography suites, with more 
characteristic examples the StentViz (GE Healthcare) and 
the StentBoost (Philips) protocols. A cine run of 3 seconds 
at 15 fps is acquired with the balloon and stent markers in 
place. With the press of a button the software automati-
cally detects both the guidewire and the stent markers and 
performs an elastic registration that allows the system to 
compensate for non-rigid stent deformation. Its simplicity 
offers the possibility of immediate and routine control of 
stent deployment. 
In the present case StentViz was initially useful in order 
FIGURE 4. A. Angiographic image after 
intra-stent and post-stent lesion further 
pre-dilatation with a 3.5x15 mm non-
compliant balloon. B. A TAXUS Element 
3.5x38 mm DES is implanted to cover the 
old BMS. C. Stent Viz after B. The red 
arrows show the proximal and the distal 
edges of the two-layer stent area which is 
more opaque. D. The long DES was not 
sufficient to entirely cover the post-stent 
mid RCA lesion and a TAXUS 3.5x12 mm 
stent was also implanted under StentViz 
control to ensure accurate positioning and 
a minimal 1-2 mm overlapping zone. After 
the second stent implantation Stent Viz 
shows here the two TAXUS stents small 
overlapping zone (white arrow) and the 
distal end of the proximal two-layer stent 
area (red arrow). BMS = bare metal stent; 
DES = drug-eluting stent
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to assess the old stent after wire and balloon crossing. Stent 
undersizing and underexpansion were present, which are both 
known as procedural factors linked to restenosis.1, 2 Subse-
quently it was used to ensure sufficient predilatation prior to 
the first long DES deployment and to accurately implant it in 
order to entirely cover the old stent. Furthermore, it was used 
to accurately position and implant the second DES in order 
to achieve a minimal overlap zone of the two DES, since DES 
overlapping is related to delayed arterial healing, inflammation 
persistence and potential late DES thrombosis.3, 4 Finally, it 
was used to control intra-stent high pressure post-dilatation 
in order to ensure optimal stent expansion. 
In conclusion, novel stent visualization enhancement tech-
nology is a practical tool that when available it permits routine 
post-implantation accurate stent assessment, which can be es-
pecially useful in complex PCI cases involving multiple stents. 
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FIGURE 5. A. Stent Viz before and B. After 
intra-stent post-dilatation with the 3.5x15 mm 
non-compliant balloon at high pressure. C. 
Proximal stented zone after post-dilatation at 
high-pressure. D. Final angiographic result.
